Menopausal hormone therapy use and risk of ovarian cancer by race: the ovarian cancer in women of African ancestry consortium

被引:0
|
作者
Jessica L. Petrick
Charlotte E. Joslin
Courtney E. Johnson
T. Fabian Camacho
Lauren C. Peres
Elisa V. Bandera
Mollie E. Barnard
Alicia Beeghly
Traci N. Bethea
Lauren F. Dempsey
Kristin Guertin
Holly R. Harris
Patricia G. Moorman
Evan R. Myers
Heather M. Ochs-Balcom
Will Rosenow
V. Wendy Setiawan
Anna H. Wu
Joellen M. Schildkraut
Lynn Rosenberg
机构
[1] Slone Epidemiology Center at Boston University,Department of Ophthalmology and Visual Sciences
[2] University of Illinois at Chicago School of Medicine,Division of Epidemiology and Biostatistics
[3] University of Illinois at Chicago School of Public Health,Department of Epidemiology, Rollins School of Public Health
[4] Emory University,Department of Public Health Sciences
[5] University of Virginia,Department of Cancer Epidemiology
[6] H. Lee Moffitt Cancer Center and Research Institute,Cancer Epidemiology and Health Outcomes
[7] Rutgers Cancer Institute of New Jersey,Department of Medicine, Division of Epidemiology
[8] Vanderbilt University Medical Center,Office of Minority Health and Health Disparities Research, Georgetown Lombardi Comprehensive Cancer Center
[9] Georgetown University Medical Campus,Department of Public Health Sciences
[10] University of Connecticut School of Medicine,Program in Epidemiology
[11] Division of Public Health Sciences,Department of Epidemiology, School of Public Health
[12] Fred Hutchinson Cancer Research Center,Department of Obstetrics and Gynecology
[13] University of Washington,Department of Family Medicine and Community Health
[14] Duke University Medical Center,Department of Epidemiology and Environmental Health, School of Public Health and Health Professions
[15] Duke University Medical Center,undefined
[16] University at Buffalo,undefined
[17] The State University of New York,undefined
[18] University of Southern California Norris Comprehensive Cancer Center and Department of Population and Public Health Sciences,undefined
[19] Keck School of Medicine,undefined
[20] University of Southern California Norris Comprehensive Cancer Center,undefined
来源
British Journal of Cancer | 2023年 / 129卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1956 / 1967
页数:11
相关论文
共 50 条
  • [21] Menopausal Hormone Replacement Therapy and the Risk of Ovarian Cancer: A Meta-Analysis
    Liu, Yang
    Ma, Lan
    Yang, Xiaoling
    Bie, Jia
    Li, Dongya
    Sun, Chunyi
    Zhang, Jie
    Meng, Yushi
    Lin, Jie
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [22] Worry about ovarian cancer risk and use of ovarian cancer screening by women at risk for ovarian cancer
    Andersen, MR
    Peacock, S
    Nelson, J
    Wilson, S
    McIntosh, M
    Drescher, C
    Urban, N
    GYNECOLOGIC ONCOLOGY, 2002, 85 (01) : 3 - 8
  • [23] Physical inactivity is associated with ovarian cancer in women of African ancestry
    Minlikeeva, Albina
    Lima, Sarah M.
    Johnson, Courtney
    Bandera, Elisa V.
    Beeghly-Fadiel, Alicia
    Bethea, Traci N.
    Petrick, Jessica
    Joslin, Charlotte E.
    Myers, Evan
    Harris, Holly R.
    Peres, Lauren C.
    Setiawan, V. Wendy
    Wu, Anna H.
    Rosenberg, Lynn
    Schildkraut, Joellen M.
    Ochs-Balcom, Heather M.
    CANCER RESEARCH, 2024, 84 (05)
  • [25] Hysterectomy and risk of epithelial ovarian cancer by histologic type, endometriosis, and menopausal hormone therapy
    Ring, Linea Landgrebe
    Baandrup, Louise
    Zheng, Guoqiao
    Gottschau, Mathilde
    Dehlendorff, Christian
    Mellemkjaer, Lene
    Kjaer, Susanne K.
    CANCER EPIDEMIOLOGY, 2023, 84
  • [26] Menopausal hormone therapy and risk of ovarian cancer: systematic review and meta-analysis
    Greiser, Claudia M.
    Greiser, Eberhard M.
    Doeren, Martina
    HUMAN REPRODUCTION UPDATE, 2007, 13 (05) : 453 - 463
  • [27] Analgesic Use and Ovarian Cancer Risk: An Analysis in the Ovarian Cancer Cohort Consortium EDITORIAL COMMENT
    Trabert, Britton
    Poole, Elizabeth M.
    White, Emily
    Visvanathan, Kala
    Adami, Hans-Olov
    Anderson, Garnet L.
    Brasky, Theodore M.
    Brinton, Louise A.
    Fortner, Renee T.
    Gaudet, Mia
    Hartge, Patricia
    Hoffman-Bolton, Judith
    Jones, Michael
    Lacey, James V., Jr.
    Larsson, Susanna C.
    Mackenzie, Gerardo G.
    Schouten, Leo J.
    Sandler, Dale P.
    O'Brien, Katie
    Patel, Alpa V.
    Peters, Ulrike
    Prizment, Anna
    Robien, Kim
    Setiawan, Wendy V.
    Swerdlow, Anthony
    van den Brandt, Piet A.
    Weiderpass, Elisabete
    Wilkens, Lynne R.
    Wolk, Alicja
    Wentzensen, Nicolas
    Tworoger, Shelley S.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2018, 73 (10) : 576 - 578
  • [28] Identification of novel epithelial ovarian cancer loci in women of African ancestry
    Manichaikul, Ani
    Peres, Lauren C.
    Wang, Xin-Qun
    Barnard, Mollie E.
    Chyn, Deanna
    Sheng, Xin
    Du, Zhaohui
    Tyrer, Jonathan
    Dennis, Joseph
    Schwartz, Ann G.
    Cote, Michele L.
    Peters, Edward
    Moorman, Patricia G.
    Bondy, Melissa
    Barnholtz-Sloan, Jill S.
    Terry, Paul
    Alberg, Anthony J.
    Bandera, Elisa, V
    Funkhouser, Ellen
    Wu, Anna H.
    Pearce, Celeste Leigh
    Pike, Malcom
    Setiawan, Veronica Wendy
    Haiman, Christopher A.
    Palmer, Julie R.
    LeMarchand, Loic
    Wilkens, Lynne R.
    Berchuck, Andrew
    Doherty, Jennifer A.
    Modugno, Francesmary
    Ness, Roberta
    Moysich, Kirsten
    Karlan, Beth Y.
    Whittemore, Alice S.
    McGuire, Valerie
    Sieh, Weiva
    Lawrenson, Kate
    Gayther, Simon
    Sellers, Thomas A.
    Pharoah, Paul
    Schildkraut, Joellen M.
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (11) : 2987 - 2998
  • [29] Hormone replacement therapy and the risk of ovarian cancer
    Risch, HA
    GYNECOLOGIC ONCOLOGY, 2002, 86 (02) : 115 - 117
  • [30] Hormone therapy increases ovarian cancer risk
    Tanday, Sanjay
    LANCET ONCOLOGY, 2015, 16 (03): : E112 - E112